+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04122313

Study of Radiation After Contracture Release Surgery for Dupuytrens Disease to Evaluate Effectiveness

Led by University of Minnesota · Updated on 2026-03-19

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the treatment pathway for Dupuytrens Disease, specifically looking at the combination of contracture release treatments followed by radiation therapy. This observational pilot study aims to provide scientific evidence supporting the clinical impression that patients improve with this current treatment approach. The study is sponsored by the University of Minnesota and focuses on assessing patient outcomes over time using established scoring systems. Participants will receive standard care for Dupuytrens Disease, which includes contracture release procedures such as limited fasciectomy, percutaneous needle aponeurotomy PNA, and collagenase Clostridium histolyticum CCH injections. Following surgery, they will undergo radiation therapy consisting of two courses five daily treatments of 300 cGy to the palm, a 6-8 week break, then a second five-day course of 300 cGy, totaling 3000 cGy in 10 fractions. This dosing follows commonly used schedules documented in medical literature. Throughout the study, participants condition will be monitored through the Southampton Dupuytrens score, clinical history, symptom tracking, and hand photographs. Assessments occur at baseline before surgery, during radiation planning, about six weeks after completing radiation, and again at one and two years post-radiotherapy. Researchers will also monitor adverse events using recognized criteria over two years. The study involves no additional interventions beyond standard care and collects patient-reported outcomes and medical record data to evaluate long-term effectiveness and safety.

CONDITIONS

Brief Title

Post-contracture Release Radiation for Dupuytren's Disease

Research Team

L

Leslie Chang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here